A novel FDA Generally Recognized as Safe (GRAS) eligible polyphenol blend with proven antiviral effects and potential applications as medication or supplements
Equivir is a compound with demonstrated antiviral effects. Patent issued in the United States.
Approved
Equivir-G adds gallic acid to the Equivir composition, resulting in another unique formulation with demonstrated antiviral effects. Patent issued in the United States.
Approved
Each year, over 17 billion upper respiratory infections occur worldwide (eClinical Medicine), driving increased demand for over-the-counter health supplements and symptomatic treatments. Equivir and Equivir-G have demonstrated antiviral effects, making them potential options as health supplements or medications. New formulations do not rely on zinc as a core component, providing an effective option for respiratory infections without the unpleasant aftertaste often linked with it.
Prophase Labs (NASDAQ: PRPH) is a global development & commercialization partner with a focus on antiviral, health supplement and pharmaceuticals
Get the latest news delivered to your inbox
